Literature DB >> 17267593

Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe.

Justen Manasa1, Hazvineyi Musabaike, Collen Masimirembwa, Eileen Burke, Ruedi Luthy, James Mudzori.   

Abstract

A single-platform volumetric flow cytometer, the Partec Cyflow SL_3, was evaluated against a BD FACSCalibur/Sysmex XT1800i dual platform for measuring CD4(+) lymphocytes, total lymphocytes, and the percentage of CD4 lymphocytes in whole-blood samples for monitoring the immune systems of human immunodeficiency virus (HIV)/AIDS patients. Statistical analyses for precision, correlation, and agreement were performed. Coefficients of variation (CV) of 5.8, 4.6, and 3.9% were obtained for low, medium, and high CD4(+) cell counts, respectively, using the SL_3, and CV of 3.7, 4.0, and 0.94 were obtained for the same categories, using the BD FACSCalibur. Significant correlations (P < 0.005) between the two assays for CD4 counts, total lymphocyte counts, and percentages of CD4 were obtained, with correlation coefficients of 0.99, 0.96, and 0.99, respectively (n = 229). Using the Bland-Altman plot, mean biases of -18 cell/microl (95% confidence interval (CI); -91 to 54 cells/microl), -0.8% (95% CI; -3.6 to 2%), and -36.8 cells/microl (95% CI; -477 to 404 cells/microl) were obtained for comparisons of CD4 counts, percentages of CD4 cells, and total lymphocyte counts, respectively. The effects of the age of the samples on the three parameters were also analyzed by comparing results from the same samples analyzed at 6, 24, and 48 h after collection. The correlation coefficients for comparisons among different time points for the same machine and among all the time points for the two different machines were greater than 0.90. These data showed that the Partec Cyflow SL_3 assay is comparable to the BD FACSCalibur/Sysmex XT1800i dual-platform method for measuring the amount of CD4(+) cells and total lymphocytes and the percentages of CD4 cells in blood samples for the purpose of monitoring HIV/AIDS patients.

Entities:  

Mesh:

Year:  2007        PMID: 17267593      PMCID: PMC1828850          DOI: 10.1128/CVI.00416-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  12 in total

1.  Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group.

Authors:  K A Reimann; M R O'Gorman; J Spritzler; C L Wilkening; D E Sabath; K Helm; D E Campbell
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group.

Authors:  C T Schnizlein-Bick; J Spritzler; C L Wilkening; J K Nicholson; M R O'Gorman
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

3.  Health-related quality of life after 1 year of highly active antiretroviral therapy.

Authors:  Patrizia Carrieri; Bruno Spire; Ségolène Duran; Christine Katlama; Dominique Peyramond; Cécile François; Geneviève Chêne; Jean-Marie Lang; Jean-Paul Moatti; Catherine Leport
Journal:  J Acquir Immune Defic Syndr       Date:  2003-01-01       Impact factor: 3.731

4.  Generic HIV drugs--enlightened policy for global health.

Authors:  Mark A Wainberg
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

5.  Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting.

Authors:  Godwin E Imade; Bitrus Badung; Sunday Pam; Oche Agbaji; Daniel Egah; Atiene S Sagay; Jean-Louis Sankalé; Saidi Kapiga; John Idoko; Phyllis Kanki
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

6.  Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda.

Authors:  Heiko Karcher; Dankmar Böhning; Robert Downing; Silver Mashate; Gundel Harms
Journal:  Cytometry B Clin Cytom       Date:  2006-05       Impact factor: 3.058

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide.

Authors:  Uwe Cassens; Wolfgang Göhde; Gudrun Kuling; Arndt Gröning; Peter Schlenke; Leopold Gustave Lehman; Yves Traoré; Jean Servais; Yvette Henin; Doris Reichelt; Burkhard Greve
Journal:  Antivir Ther       Date:  2004-06

9.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

10.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  17 in total

Review 1.  Diagnostic point-of-care tests in resource-limited settings.

Authors:  Paul K Drain; Emily P Hyle; Farzad Noubary; Kenneth A Freedberg; Douglas Wilson; William R Bishai; William Rodriguez; Ingrid V Bassett
Journal:  Lancet Infect Dis       Date:  2013-12-10       Impact factor: 25.071

2.  Validation of a single-platform, volumetric, CD45-assisted PanLeucogating Auto40 flow cytometer to determine the absolute number and percentages of CD4 T cells in resource-constrained settings using Cameroonian patients' samples.

Authors:  François-Xavier Mbopi-Kéou; Stefano Mion; Bertrand Sagnia; Laurent Bélec
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

3.  Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Authors:  Sabelle Jallow; Abraham Alabi; Ramu Sarge-Njie; Kevin Peterson; Hilton Whittle; Tumani Corrah; Assan Jaye; Matthew Cotten; Guido Vanham; Samuel J McConkey; Sarah Rowland-Jones; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

4.  Effect of risedronate in osteoporotic HIV males, according to gonadal status: a pilot study.

Authors:  J Pepe; A M Isidori; M Falciano; G Iaiani; A Salotti; D Diacinti; R Del Fiacco; E Sbardella; C Cipriani; S Piemonte; O Raimo; P Biondi; F Biamonte; A Lenzi; S Minisola
Journal:  Endocrine       Date:  2014-08-08       Impact factor: 3.633

5.  Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?

Authors:  Samuel Nyamweya; John Townend; Akram Zaman; Sarah Jane Steele; David Jeffries; Sarah Rowland-Jones; Hilton Whittle; Katie L Flanagan; Assan Jaye
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

6.  Evaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.

Authors:  Matilu Mwau; Ferdinard Adungo; Silvia Kadima; Ephantus Njagi; Carolyne Kirwaye; Najma Salim Abubakr; Lucy Atsieno Okubi; Mary Waihenya; Judi Lusike; Jackson Hungu
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

7.  Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe.

Authors:  Mqondisi Tshabalala; Justen Manasa; Lynn S Zijenah; Simbarashe Rusakaniko; Gerard Kadzirange; Mary Mucheche; Seble Kassaye; Elizabeth Johnston; David Katzenstein
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

8.  Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

Authors:  Martin W G Brinkhof; Andrew Boulle; Ralf Weigel; Eugène Messou; Colin Mathers; Catherine Orrell; François Dabis; Margaret Pascoe; Matthias Egger
Journal:  PLoS Med       Date:  2009-04-28       Impact factor: 11.069

9.  Single-platform, volumetric, CD45-assisted pan-leucogating flow cytometry for CD4 T lymphocytes monitoring of HIV infection according to the WHO recommendations for resource-constrained settings.

Authors:  Donato Koyalta; Mohammad-Ali Jenabian; Ngamasra Nadjiouroum; Barou Djouater; Noël Djemadji-Oudjeil; Angélique Ndjoyi-Mbiguino; Laurent Bélec
Journal:  BMC Res Notes       Date:  2013-04-30

10.  CD4 T-cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-dry and Pima CD4 systems.

Authors:  Djibril Wade; Papa Alassane Diaw; Géraldine Daneau; Makhtar Camara; Tandakha Ndiaye Dieye; Souleymane Mboup; Luc Kestens
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.